Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DI9ZQ6
|
|||
| Drug Name |
212Pb-labelled aCD37
|
|||
| Synonyms |
212PB-NNV003
Click to Show/Hide
|
|||
| Drug Type |
Radiopharmaceutical therapy agent
|
|||
| Indication | leukaemia [ICD-11: 2A60-2B33; ICD-10: C91-C95; ICD-9: 204-208] | Preclinical | [1] | |
| Company |
OranoMed/NordicNanovector
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Leukocyte antigen CD37 (CD37) | Target Info | . | [1] |
| KEGG Pathway | Hematopoietic cell lineage | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Radiopharmaceutical therapy in cancer: clinical advances and challenges. Nat Rev Drug Discov. 2020 Sep;19(9):589-608. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.